Items where authors include "Salem, A."

Article

Nepogodiev, D., Nepogodiev, D., Kamarajah, S.K. et al. (23258 more authors) (2026) 30-day postoperative mortality and the effects of hospital preparedness during the COVID-19 pandemic: a pooled analysis of prospective international cohort studies. The Lancet Regional Health - Europe, 62. 101566. ISSN 2666-7762

Tseng, P.-L., Sun, W., Salem, A. et al. (5 more authors) (2025) Mechanical control of the alternative splicing factor PTBP1 regulates extracellular matrix stiffness induced proliferation and cell spreading. iScience, 28 (4). 112273. ISSN 2589-0042

Mellor, J. orcid.org/0000-0003-1452-887X, Kuznetsov, D. orcid.org/0000-0002-9972-947X, Heller, S. orcid.org/0000-0002-2425-9565 et al. (15 more authors) (2024) Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia, 67 (10). pp. 2210-2224. ISSN 0012-186X

Mellor, J. orcid.org/0000-0003-1452-887X, Kuznetsov, D. orcid.org/0000-0002-9972-947X, Heller, S. orcid.org/0000-0002-2425-9565 et al. (15 more authors) (2024) Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia, 67 (8). pp. 1588-1601. ISSN 0012-186X

Salem, A., Franks, K., Greystoke, A. et al. (6 more authors) (2022) Unaccounted confounders limit the ability to draw conclusions from big data analysis comparing radiotherapy fractionation regimens in NSCLC. Journal of Thoracic Oncology, 17 (6). e55-e56. ISSN 1556-0864

Salem, A., Mistry, H., Hatton, M. et al. (4 more authors) (2019) Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial. JAMA Oncology, 5 (3). e185335. ISSN 2374-2437

Conference abstract

Horne, A., Ali, A., Brown, S. et al. (28 more authors) (2022) 153 CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). [Conference abstract]